Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prevention of Anthrax Infection”

9 trials

Showing 9 of 9 results

Early research (Phase 1)Study completedNCT00103467
What this trial is testing

Trial to Evaluate the Safety and Immunogenicity of an Anthrax Recombinant Protective Antigen Vaccine

Who this might be right for
Prevention of Anthrax Infection
VaxGen 100
Testing effectiveness (Phase 2)Study completedNCT01770743
What this trial is testing

Safety and Immunogenicity Study for an Anthrax Vaccine Using 3 Schedules and Two Dose Levels

Who this might be right for
Anthrax
Emergent BioSolutions 168
Testing effectiveness (Phase 2)Study completedNCT03518125
What this trial is testing

BARDA Securing Anthrax Immunity For the Elderly

Who this might be right for
Anthrax
Biomedical Advanced Research and Development Authority 305
Post-approval studies (Phase 4)Study completedNCT01641991
What this trial is testing

Assessment of the Immunogenicity and Safety of a Dose-Sparing BioThrax® AVA Schedule

Who this might be right for
Bacillus Anthracis (Anthrax)
National Institute of Allergy and Infectious Diseases (NIAID) 328
Testing effectiveness (Phase 2)Study completedNCT01753115
What this trial is testing

Ciprofloxacin BioThrax Co-Administration Study

Who this might be right for
Anthrax
Emergent BioSolutions 154
Testing effectiveness (Phase 2)Study completedNCT00170456
What this trial is testing

Phase II Study of Range and Schedule of rPA Doses

Who this might be right for
Prevention of Bacillus Anthracis (Anthrax) Infection
PharmAthene UK Limited 415
Large-scale testing (Phase 3)Study completedNCT03877926
What this trial is testing

VELOCITY: An Anthrax Vaccine Clinical Study

Who this might be right for
Anthrax
Emergent BioSolutions 3,862
Large-scale testing (Phase 3)Study completedNCT01491607
What this trial is testing

Immunogenicity and Safety Study of a Three-Dose BioThrax® Regimen for Post-Exposure Prophylaxis in Healthy Adults

Who this might be right for
Anthrax
Emergent BioSolutions 200
Not applicableNot Yet RecruitingNCT07268612
What this trial is testing

Evaluation of Clinical Benefit and Safety Following CYFENDUS Administration for Post-Exposure Prophylaxis of Anthrax Disease.

Who this might be right for
Anthrax
Emergent BioSolutions 250

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation